Engaged Capital 13F, Q3 2025

Glenn Welling · quarter ending 30 September 2025 · filed 14 November 2025 · SEC CIK 1559771

$407.63M
Filed US book
9
Positions
20.8%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q3 2025

Weights are against the whole filed book. Changes are in shares held, against the Q2 2025 filing.

CompanyTickerValue% of bookvs Q2 2025
V F CORPVFC$84.59M20.8%+8% shares
YETI HLDGS INCYETI$71.99M17.7%unchanged
GXO LOGISTICS INCORPORATEDGXO$51.75M12.7%+9% shares
EVOLENT HEALTH INCEVH$47.92M11.8%-3% shares
COGNEX CORPCGNX$38.73M9.5%new
FRESHPET INCFRPT$34.12M8.4%unchanged
PORTILLOS INCPTLO$32.70M8.0%+5% shares
BLACKLINE INCBL$24.10M5.9%new
BRC INCBRCC$21.74M5.3%+3% shares

What changed since Q2 2025

Against the Q2 2025 filing, Engaged Capital opened 2 new positions, added to 4, trimmed 1, left 2 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

Nothing from the previous filing was sold outright.

Added to

Trimmed

Other quarters

Source: SEC Form 13F-HR, accession 0000921895-25-003080, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.